Dow Hits New High as Warsh Takes Fed Oath: Stock Market Today

Why It Matters

Warsh’s appointment could steer monetary policy amid inflation concerns, while Merck’s trial results and Astera Labs’ rally underscore growth drivers in biotech and AI hardware that are reshaping market dynamics.

Key Takeaways

• Dow Jones closes at record 50,579, up 0.6%
• Kevin Warsh sworn Fed chair, first presidential observation since 1987
• Merck's partner reports 65% lung‑cancer risk reduction with Keytruda combo
• Astera Labs jumps 43.6% after upgraded target to $297

Pulse Analysis

The Dow’s new closing high reflects a market that remains resilient despite elevated oil prices and rising Treasury yields. Investors are weighing the implications of Kevin Warsh’s swearing‑in as Fed chair, a rare moment of presidential presence that signals potential political backing for lower rates. Yet the 2‑year Treasury yield hovering above 4% suggests markets are still bracing for possible policy tightening, making the equity rally a nuanced balance between optimism and caution.

In the healthcare arena, Merck’s performance was buoyed by a breakthrough from its Chinese partner Kelun‑Biotech. The Phase III trial demonstrated a 65% cut in tumor progression risk when the experimental sac‑TMT was paired with Merck’s flagship immunotherapy, Keytruda. This data not only strengthens Merck’s pipeline as Keytruda approaches the end of its exclusivity in 2028, but also reinforces the strategic value of international collaborations in accelerating drug development and extending revenue streams for legacy pharma firms.

The semiconductor sector continued to capture investor attention, with Astera Labs leading a rally after analysts raised its 12‑month target to $297. The stock’s 43.6% jump underscores the market’s confidence in AI‑driven data‑center spending, particularly for inference workloads projected to surge in the latter half of 2026. While broader chip ETFs faced modest declines, the episode highlights how targeted, high‑growth names can outperform in a landscape where capital allocation increasingly favors AI‑centric hardware solutions.